Global law firm K&L Gates LLP welcomes Kate Spelman as a technology transactions partner in the firm’s Seattle office. Spelman joins K&L Gates from Cobalt LLP.
Tags: K&L Gates LLP
Paul Hastings Advises Nomura and Other Banks in Financing AsiaInfo-Linkage’s US$890 Million Take-Private
Paul Hastings, a leading global law firm, announced today that it is representing Nomura, Bank of Taiwan, Cathay United Bank, Co., LTD., ICBC International Capital Limited and Maybank Investment Bank Berhad, as mandated lead arrangers in connection with the US$330 million debt financing for AsiaInfo-Linkage, Inc.’s take-private acquisition by a consortium led by Chinese private equity company CITIC Capital Partners in an all-cash deal valued at approximately US$890 million.
Tags: Paul Hastings, LLP | Hong Kong
Steptoe’s Chicago Office Expands, Adds Trio of Patent Litigators
Steptoe & Johnson LLP is again expanding its national intellectual property litigation practice and its growing Chicago office with the addition of three patent litigators. Joining as partners are James “Jay” Nuttall, John Abramic, and Glen Belvis.
Tags: Steptoe & Johnson PLLC
McDermott Advises Constellation Brands in $1.55 Billion Senior Notes Offering
International law firm McDermott Will & Emery LLP represented Constellation Brands, Inc., the world’s leading premium wine company, in its issuance on May 14, 2013 of $1.05 billion aggregate principal amount of Senior Notes due 2023 and $500 million aggregate principal amount of Senior Notes due 2021 in a public offering under a shelf registration statement filed with the Securities and Exchange Commission.
Tags: McDermott Will & Emery LLP
Akin Gump Advises CITIC PE on Take-Private of AsiaInfo-Linkage
A team of Akin Gump Strauss Hauer & Feld LLP attorneys is advising CITIC PE in relation to the management buyout of AsiaInfo-Linkage by a consortium that would take the company private.
Tags: Akin Gump Strauss Hauer & Feld LLP | Hong Kong
Kaye Scholer to Represent Convertible Bondholders in €4B Restructuring of IVG Immobilien AG
A large group of institutional investors, comprising mostly US and UK hedge funds, appointed Bankruptcy & Restructuring Partners David von Saucken and Paul Atherton in Kaye Scholer’s London office to represent them as convertible bondholders in the restructuring of IVG Immobilien AG. IVG is a German-listed public company with approximately 550 employees at 19 locations in major German and European cities. It manages assets totaling over €21 billion with a particular focus on real estate and infrastructure.
Tags: Arnold & Porter Kaye Scholer LLPStamford Law Continues to Build on Corporate Strengths with Additional International Firm Hire
Davis Polk Advises the French State on the Sale of a 3.6% Stake in EADS
Davis Polk advised the French State in connection with the disposal of 1.5% of the total share capital of EADS, completed on April 16, 2013, through a share buyback for a total amount of €483 million, and a subsequent private placement by way of an accelerated book-building relating to 2.1% of the total share capital for a total amount of €707 million and completed on May 2, 2013.
Tags: Davis Polk & Wardwell LLP | New YorkDavis Polk – Capitol Acquisition Corp. II IPO
Davis Polk advised Citigroup Global Markets Inc. and Deutsche Bank Securities Inc. as joint book-running managers in connection with the initial public offering of 20,000,000 units of Capitol Acquisition Corp. II, including 2,000,000 units purchased pursuant to the underwriters’ over-allotment option, for an aggregate of $200 million. Each unit consists of one share of common stock and one-half of one warrant to purchase one share of common stock of Capitol Acquisition Corp. II. The units, the shares and the warrants will be listed on the Nasdaq Capital Market.
Tags: Davis Polk & Wardwell LLP | New YorkDavis Polk – Isis Pharmaceuticals, Inc. Common Stock Offering
Davis Polk advised Goldman, Sachs & Co. and J.P. Morgan Securities LLC as representatives of the several underwriters in connection with an SEC-registered offering of 9,000,000 shares of common stock of Isis Pharmaceuticals, Inc. The gross proceeds from the offering were $171 million. The common stock is listed on The Nasdaq Global Select Market under the symbol “ISIS.”
Tags: Davis Polk & Wardwell LLP | Silicon Valley